ATRA Live-Signale | Maximieren Sie Profite mit Getagraph.com

KAUFEN 107403 min ago

@ $0.771

Ausgestellt: 14 Feb 2024 @ 19:55

Rendite: -10.52%

Vorheriges Signal: Feb 13 - 21:34

Vorheriges Signal: Verkaufen

Rendite: -0.05 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 22:00):

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States...

Stats
Tagesvolumen	519 733
Durchschnittsvolumen	2.67M
Marktkapitalisierung	82.36M
EPS	$0 ( 2024-03-27 )
Nächstes Ertragsdatum	( $-0.370 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.260
ATR14	$0.00200 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Fust Matthew K	Buy	150 000	Common Stock
2024-03-31	Heiden William K	Buy	150 000	Common Stock
2024-03-31	Roncarolo Maria Grazia	Buy	150 000	Common Stock
2024-03-31	Gallagher Carol Giltner	Buy	150 000	Common Stock
2024-03-31	Mallik Ameet	Buy	150 000	Common Stock

INSIDER POWER
70.32
Last 100 transactions
Buy: 8 350 944 \| Sell: 2 074 393

Volumen Korrelation

Lang: -0.13 (neutral)

Kurz: 0.82 (strong)

Signal:(52.538) Same movement expected

Atara Biotherapeutics Inc Korrelation

10 Am meisten positiv korreliert
SRTS	0.965
CDXS	0.964
LGHL	0.959
ZD	0.957
ZYNE	0.952
RKDA	0.95
ATER	0.949
HNNA	0.948
NMTR	0.948
DYNT	0.946

10 Am meisten negativ korreliert
MCAA	-0.951
MSDA	-0.949
CITE	-0.945
DHAC	-0.944
AHRN	-0.942
LEGA	-0.942
ADAL	-0.942
FTAA	-0.94
PFTA	-0.939
ZING	-0.939

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Atara Biotherapeutics Inc Korrelation - Währung/Rohstoff

-0.60
( weak negative )

-0.57
( weak negative )

0.00
( neutral )

0.85
( strong )

Atara Biotherapeutics Inc Finanzdaten

Annual	2023
Umsatz:	$8.57M
Bruttogewinn:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2023
Umsatz:	$8.57M
Bruttogewinn:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2022
Umsatz:	$63.57M
Bruttogewinn:	$49.01M (77.08 %)
EPS:	$-2.24

FY	2021
Umsatz:	$20.34M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-3.63

Financial Reports:

No articles found.

Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.